| Name | Title | Contact Details |
|---|
Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.
CenterLight Health System ranks among the nation`s leading resources for long-term residential and community-based health care. A voluntary, nonprofit organization, CenterLIght has made life better for tens of thousands of New Yorkers from all backgrounds and walks of life. It first opened its doors to the poor, chronically ill and disabled just after the First World War.
Family Service League is a nationally accredited human services agency that has taken an active role in strengthening families and empowering the residents of Long Island for more than 90 years. We currently have over 50 programs in 21 locations, including 5 Family Centers, designed to help children, families in crisis, senior citizens, people who are homeless, unemployed, or mentally ill. Family Service League works to give them the resources they need in order to be self-reliant and productive members of our communities.
Healthways, a Sharecare company, is a global provider of well-being improvement solutions. Dedicated to creating a healthier world one person at a time, the company uses the science of behavior change to produce and measure positive change in well-being for our customers, which include employers, integrated health systems, hospitals, physicians, health plans, communities and government entities.
Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin`s product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Vascepa® (icosapent ethyl) is Amarin`s first FDA approved product and is available in the United States by prescription.